Investigation of Crystal Structures in Structure-Based Virtual Screening for Protein Kinase Inhibitors

被引:9
|
作者
Chen, Xingye [1 ]
Liu, Haichun [1 ]
Xie, Wuchen [1 ]
Yang, Yan [1 ]
Wang, Yuchen [1 ]
Fan, Yuanrong [1 ]
Hua, Yi [1 ]
Zhu, Lu [1 ]
Zhao, Junnan [1 ]
Lu, Tao [1 ,2 ]
Chen, Yadong [1 ]
Zhang, Yanmin [1 ]
机构
[1] China Pharmaceut Univ, Sch Sci, Lab Mol Design & Drug Discovery, 639 Longmian Ave, Nanjing 211198, Jiangsu, Peoples R China
[2] China Pharmaceut Univ, State Key Lab Nat Med, 24 Tongjiaxiang, Nanjing 210009, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
MOLECULAR DOCKING; DRUG DESIGN; DISCOVERY; POTENT; DERIVATIVES; RECEPTOR; OPTIMIZATION; PERFORMANCE; ALGORITHM; TARGETS;
D O I
10.1021/acs.jcim.9b00684
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Protein kinases are important drug targets in several therapeutic areas,and structure-based virtual screening (SBVS) is an important strategy in discovering lead compounds for kinase targets. However, there are multiple crystal structures available for each target, and determining which one is the most favorable is a key step in molecular docking for SBVS due to the ligand induce-fit effect. This work aimed to find the most desirable crystal structures for molecular docking by a comprehensive analysis of the protein kinase database which covers 190 different kinases from all eight main kinase families. Through an integrated self-docking and cross-docking evaluation, 86 targets were eventually evaluated on a total of 2608 crystal structures. Results showed that molecular docking has great capability in reproducing conformation of crystallized ligands and for each target, the most favorable crystal structure was selected, and the AGC family outperformed the other family targets based on RMSD comparison. In addition, RMSD values, GlideScore, and corresponding bioactivity data were compared and demonstrated certain relationships. This work provides great convenience for researchers to directly select the optimal crystal structure in SBVS-based kinase drug design and further validates the effectiveness of molecular docking in drug discovery.
引用
收藏
页码:5244 / 5262
页数:19
相关论文
共 50 条
  • [21] Discovery of novel sphingosine kinase 1 inhibitors via structure-based hierarchical virtual screening
    Wang, Xiaojian
    Sun, Chenbin
    Fang, Liang
    Yin, Dali
    MEDCHEMCOMM, 2015, 6 (03) : 413 - 417
  • [22] Recent advances in structure-based drug design and virtual screening of VEGFR tyrosine kinase inhibitors
    Hoi, Pui Man
    Li, Shang
    Vong, Chi Teng
    Tseng, Hisa Hui Ling
    Kwan, Yiu Wa
    Lee, Simon Ming-Yuen
    METHODS, 2015, 71 : 85 - 91
  • [23] Ultrafast protein structure-based virtual screening with Panther
    Sanna P. Niinivehmas
    Kari Salokas
    Sakari Lätti
    Hannu Raunio
    Olli T. Pentikäinen
    Journal of Computer-Aided Molecular Design, 2015, 29 : 989 - 1006
  • [24] Identification of Novel Inhibitors of Tropomyosin-Related Kinase A through the Structure-Based Virtual Screening with Homology-Modeled Protein Structure
    Park, Hwangseo
    Chi, Okyung
    Kim, Jinhee
    Hong, Sungwoo
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2011, 51 (11) : 2986 - 2993
  • [25] Ultrafast protein structure-based virtual screening with Panther
    Niinivehmas, Sanna P.
    Salokas, Kari
    Latti, Sakari
    Raunio, Hannu
    Pentikainen, Olli T.
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2015, 29 (10) : 989 - 1006
  • [26] Structure-Based Virtual Screening of Helicobacter pylori SecA Inhibitors
    Jian, Tiantian
    Su, Qing
    Liu, Yan
    Seoh, Hyuk-Kyu
    Houghton, John Edgar
    Tai, Phang-Cheng
    Huang, Xinhe
    IEEE TRANSACTIONS ON NANOBIOSCIENCE, 2023, 22 (04) : 933 - 942
  • [27] Immunosuppressive Small Molecule Discovered by Structure-Based Virtual Screening for Inhibitors of Protein-Protein Interactions
    Geppert, Tim
    Bauer, Stefanie
    Hiss, Jan A.
    Conrad, Elea
    Reutlinger, Michael
    Schneider, Petra
    Weisel, Martin
    Pfeiffer, Bernhard
    Altmann, Karl-Heinz
    Waibler, Zoe
    Schneider, Gisbert
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2012, 51 (01) : 258 - 261
  • [28] Structure-based Virtual Screening to Get New Scaffold Inhibitors of the Ser/Thr Protein Kinase PknB from Mycobacterium tuberculosis
    Coluccia, Antonio
    La Regina, Giuseppe
    Barilone, Nathalie
    Lisa, Maria-Natalia
    Brancale, Andrea
    Andre-Leroux, Gwenalle
    Alzari, Pedro M.
    Silvestri, Romano
    LETTERS IN DRUG DESIGN & DISCOVERY, 2016, 13 (10) : 1012 - 1018
  • [29] Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening?
    Tang, Hao
    Wang, Xiang Simon
    Hsieh, Jui-Hua
    Tropsha, Alexander
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2012, 80 (06) : 1503 - 1521
  • [30] Discovery of novel checkpoint kinase 1 inhibitors by virtual screening based on multiple crystal structures
    Li, Yan
    Kim, Dong Joon
    Ma, Weiya
    Lubet, Ronald
    Bode, Ann M.
    Dong, Zigang
    CANCER RESEARCH, 2012, 72